Market Closed - Toronto S.E. 03:03:00 2024-03-28 pm EDT 5-day change 1st Jan Change
1.62 CAD +1.25% Intraday chart for Zentek Ltd. -7.43% +11.72%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zentek Says Potential COVID-19 Drug Shows 'Promising' Safety Profile in Preclinical Trial MT
Zentek Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Sector Update: Health Care Stocks Edge Up Late Afternoon MT
Sector Update: Health Care Stocks Rise in Afternoon Trading MT
Sector Update: Health Care MT
Zentek Shares Rise After Positive Preclinical Results For Covid Treatment Candidate MT
Zentek Announces "Positive" Therapeutic Results Achieved by Triera Biosciences for C19HBA MT
Zentek Brief: Announcing "Positive" Therapeutic Results achieved by Triera Biosciences for C19HBA MT
Zentek Ltd.'s Subsidiary Triera Biosciences Ltd. Completes Testing of Its C19HBA Aptamer as Potential Therapeutic CI
Zentek Ltd. Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters CI
Zentek Taps Independent Director as Board Chairman MT
Zentek Taps Independent Director as Board Chairman MT
Zentek Brief: Announcing Eric Wallman Appointed as Chairman of the Board MT
Zentek Ltd. Announces Board Changes CI
Zentek Launches Triera, a New Subsidiary, to Commercialize its Aptamer Covid-19 Treatment MT
Zentek Launches Triera Biosciences Ltd as its Wholly Owned Subsidiary CI
Zentek Signs Filter Distribution Deal With 1Click Heating; Shares Rise MT
Zentek Ltd. and 1Click Heating and Cooling Inc. Sign Distribution Agreement CI
Zentek's COVID-19 Aptamer Successfully Tested Against Omicron Variant in Pre-Clinical Study MT
Zentek Ltd. Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant CI
Zentek's CEO Appointed as Interim CEO of Albany Graphite Unit MT
Zentek Ltd. announced a financing transaction CI
Zentek Ltd. Appoints Mr. John Snisarenko to its Board of Directors CI
Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology CI
Zentek Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Chart Zentek Ltd.
More charts
Zentek Ltd. is a Canada-based graphene technology company. The principal business of the Company is to develop opportunities in the graphene and related nano-materials industry based on its intellectual property, patents and unique Albany graphite. The Company is focused on the research, development, and commercialization of graphene-based products. The Company's technology helps filter and deactivate pathogens to reduce the risk of transmission. The Company is focused on commercializing ZenGUARD, which is a hydrophilic, water attracting coating that adsorbs bacteria and virus-laden aerosols and deactivates them, increasing public safety, and reducing the risk of transmission of COVID and other pathogens. The Company is developing a graphene-based fuel additive that can reduce greenhouse gas (GHG) emissions from diesel and bio-diesel fuels. The Company’s developments include Aptamers & Rapid Detection and Graphene-Oxide Synthesis & Graphene Synthesis.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Zentek Ltd. - Toronto S.E.
  4. News Zentek Ltd.
  5. ZEN Graphene : Reaches Definitive Agreement for Manufacture of ZENGuard Surgical Masks